Department of Nephrology and Transplantation, Renal Institute of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK.
Nat Rev Nephrol. 2011 Nov 15;8(1):34-42. doi: 10.1038/nrneph.2011.174.
New-onset diabetes mellitus after kidney transplantation (NODAT) is widely acknowledged to be associated with increased morbidity and mortality, as well as poor quality of life. Clear evidence links the occurrence of NODAT to accelerated progression of some macrovascular and/or microvascular complications. However, the evidence that some complications commonly attributed to diabetes mellitus occur in the context of transplantation lacks robustness. Certain complications are transplantation-specific and prevalent, but others are not frequently observed or documented. For this reason, it is essential that clinicians are aware of the array of potential complications associated with NODAT in kidney allograft recipients. Rather than simply translating evidence from the general population to the high-risk transplant recipient, this Review aims to provide specific guidance on diabetes-related complications in the context of a complex transplantation environment.
肾移植后新发糖尿病(NODAT)被广泛认为与发病率和死亡率增加以及生活质量下降有关。有明确的证据表明,NODAT 的发生与某些大血管和/或微血管并发症的加速进展有关。然而,将一些通常归因于糖尿病的并发症归因于移植的证据并不充分。某些并发症是移植特有的且普遍存在的,但其他并发症并不经常观察到或记录在案。因此,临床医生必须了解与肾移植受者 NODAT 相关的一系列潜在并发症。本综述的目的不是简单地将来自普通人群的证据转化为高危移植受者,而是旨在提供在复杂移植环境下与糖尿病相关的并发症的具体指导。